日本醫學影像市場評估：按產品、按應用、按最終用戶、按地區、機會和預測（2018 財年-2032 財年）

日本醫學影像市場規模預計將從 2024 財年的 20.1 億美元增至 2032 財年的 29.8 億美元，預計 2025 財年至 2032 財年的複合年增長率為 5.03%。該市場的推動因素包括政府舉措和資金、不斷增長的老年人口和相關慢性疾病、技術進步、醫療保健覆蓋面的擴大、數位醫療解決方案的整合、醫療保健意識的提高、戰略合作夥伴關係以及報銷政策的改善。總的來說，這些因素正在推動對先進影像處理技術的需求，提高可近性，並推動市場的動態成長和發展。

醫學影像透過提供支持準確診斷和有效治療計劃的詳細內部影像，在醫療保健中發揮重要作用。促進疾病的早期發現、及時介入並顯著改善患者的治療效果。此外，醫學影像對於監測疾病進展和評估治療效果至關重要，以便進行必要的調整。此外，許多已開發經濟體，尤其是發展中國家醫療保健成本的成長和影像處理技術的滲透也推動了醫學影像的發展。

例如，2023年8月，人工智慧開發公司HeartVista Inc.與投資和商業化公司HekaBio KK（HekaBio）簽訂合作協議，推出一鍵式MRI人工智慧軟體Vista.ai ，在日本得出結論。根據協議，HekaBio投資了Vista.ai，並承諾透過日本厚生勞動省確保One Click MRI產品註冊。

本報告對日本醫學影像市場進行研究和分析，提供市場規模和預測、市場動態以及主要公司的狀況。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 日本的醫療圖像市場預測(2018年度～2032年度)

• 市場規模的分析與預測
  • 金額
  • 數量
• 市場佔有率的分析與預測
  • 各產品
  • 各用途
  • 各終端用戶
  • 各地區
  • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2024年度)
• 市場地圖分析(2024年度)
  • 各產品
  • 各用途
  • 各終端用戶
  • 各地區

第5章 供需分析

第6章 進口和出口的分析

第7章 價值鏈分析

第8章 波特的五力分析

第9章 大環境分析

第10章 價格分析

第11章 市場動態

• 推動市場要素
• 市場課題

第12章 市場趨勢與發展

第13章 法規結構和革新

• 法規當局的認證

第14章 專利形勢

第15章 案例研究

第16章 競爭情形

• 市場領導者前五名公司的競爭矩陣
• 前五名公司的SWOT分析
• 前十大企業的市場企業的主要企業的形勢
  • Canon Medical Systems Corporation
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Esaote SpA
  • Shimadzu Corporation
  • FUJIFILM Holdings Corporation
  • Samsung Electronics Co Ltd.
  • United Imaging Healthcare Japan
  • Carestream Health Japan Co., Ltd.

第17章 策略性推薦

第18章 本公司相關資料，免責聲明

Japan medical imaging market is projected to witness a CAGR of 5.03% during the forecast period FY2025-FY2032F, growing from USD 2.01 billion in FY2024 to USD 2.98 billion in FY2032. Japan medical imaging market is driven by several factors, which include government initiatives and funding, the growing geriatric population and subsequent rise in chronic diseases, technological advancements, expanded healthcare access, integration of digital health solutions, growing healthcare awareness, strategic partnerships, and improved reimbursement policies. These factors collectively enhance the demand for advanced imaging technologies and improve accessibility, driving the dynamic growth and evolution of the market.

Medical imaging plays a crucial role in healthcare by providing detailed internal images that support accurate diagnosis and effective treatment planning. It facilitates early detection of diseases, allowing for timely intervention and significantly improving patient outcomes. Additionally, medical imaging is vital for monitoring disease progression and assessing the effectiveness of treatments, enabling necessary adjustments. In addition, the development of the medical imaging market is also driven by healthcare expenditure growth and the penetration of imaging technologies in numerous advanced economies, especially in developing countries.

For instance, in August 2023, AI developer HeartVista Inc. signed a partnership deal with investment and commercialization firm HekaBio K.K. (HekaBio) to market its One Click MRI AI software - Vista.ai in Japan. Under the agreement, HekaBio invested in Vista.ai and committed to securing product registration for One Click MRI through the Japanese Ministry of Health, Labour and Welfare (MHLW).

Technological Innovations Propel Japan's Medical Imaging Market

Japan has one of the highest per capita diagnostic imaging devices in the world. This has resulted in a high uptake of medical imaging technologies with advanced capabilities. AI-enabled X-ray systems and computed tomography (CT) systems improve diagnostics efficiency and accuracy. The improvements resulting from these technologies reduce the time needed to acquire and interpret images, allowing healthcare providers to make decisions more quickly and provide better quality to patients. Moreover, technologies like augmented reality and 3D printing are bringing imaging to new and faster capabilities while diagnosing innovatively and accurately and creating more individualized treatment plans for patients. Furthermore, the increasing focus on earlier detection of disease and preventive health is driving demand for advanced imaging technologies and plays an important role in detecting disease earlier.

For instance, in November 2023, iSchemaView, Inc., also known as RapidAI, expanded its presence into Japan through Class III Shonin clearance for its stroke platform and launch of Rapid Edge Cloud, a hybrid technology platform.

Growing Geriatric Population and Subsequent Rise in Chronic Disease

One of the primary drivers of increasing demand for medical imaging is notably an ever-increasing occurrence of chronic diseases and disorders. An aging Japanese population rapidly requires early and precise diagnosis of cardiovascular diseases, cancers, neurodegenerative disorders, etc. As a result, sophisticated medical imaging modalities such as magnetic resonance imaging (MRI), computed tomography scans, and positron emission technology are crucial in monitoring, diagnosing, and treating these diseases. Improved diagnostic capability based on the existence of high-resolution imaging and functional imaging techniques with the Individualised treatment strategy. Furthermore, the rising incidence of these diseases requires frequent screening and follow-up, leading to the growing use of imaging services. For instance, in June 2024, Japan reached a troubling milestone with 2,977 documented cases of streptococcal toxic shock syndrome (STSS), reflecting a significant increase in chronic disease incidence. The mortality rate for STSS is alarmingly high at 30%, with 77 fatalities reported between January and March 2024, exceeding last year's total of 941 infections.

CT Scanner Segment Leads Market Share in Medical Imaging Market

CT scanners are driving the medical imaging market's growth by offering high-resolution, detailed images that are crucial for accurate diagnosis and treatment planning. Their ability to quickly provide comprehensive cross-sectional views of the body makes them essential in detecting and evaluating a wide range of conditions, from trauma and cancers to complex internal injuries. The increasing adoption of advanced CT technologies, such as high-definition and low-dose CT scanners, enhances diagnostic precision while minimizing patient exposure to radiation. Rising incidence of chronic diseases, along with complementary requirements related to quick and accurate imaging solutions for emergencies as well as routine care settings, trigger the demand for CT scanners. For instance, in April 2023, Canon Medical Systems Corporation, the National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC), and the National Cancer Center Hospital East have started joint research and a clinical trial that aims to develop new diagnostic methods and investigate their clinical value by evaluating image data obtained using the Photon Counting CT (PCCT) system installed at EPOC.

Southern Japan Dominates the Japan Medical Imaging Market

Southern regions of Japan are notable for their dominance in healthcare resources and services. These areas, particularly the western districts, exhibit a higher concentration of hospitals and medical facilities compared to other regions. The southern prefectures have developed robust healthcare networks, which enhance accessibility and improve health outcomes for local populations. The workflow and financial stability in the region are capable of high expenditure on health services, as well as its penetration for the adoption of new X-ray imaging devices. Additionally, the existence of top research organizations and technology firms boosts the medical imaging market in the region; besides that, significant investments in healthcare infrastructure and technologies by the government as well as from the private sector are strengthening its market growth further. The impact of these, together with other factors, gives Southern Japan a dominant position in the medical imaging sector.

For instance, in April 2024, leading healthcare and sustainability entrepreneurs and investors converged in Okinawa for the inaugural "OIST-Lifetime Startup Elevate 2024," a premier event designed to spotlight innovative startups and groundbreaking technologies in these critical fields. Hosted by the Okinawa Institute of Science and Technology (OIST), the event aimed to foster connections, inspire collaboration, and drive investment in transformative solutions that address pressing global challenges.

Future Market Scenario (FY2025-FY2032F)

Japan's healthcare industry is the new favourite for AI start-ups. New artificial intelligence-based healthcare tools focus on how doctors determine whether cancer, influenza, and heart disease float across blood. Public-private collaborations are also encouraging the use of more AI healthcare tools by Japan's medical industry. In addition, the investment by Japan in the AI research and development sector along with governmental efforts to improve healthcare technology will help develop a conducive environment for medical imaging deployment of AI. For instance, in December 2022, Japan announced its initiative to accelerate the approval process for AI diagnostic imaging equipment and ease regulations on medical AI software. This move is part of the broader Society 5.0 program, which seeks to develop a society enriched by cutting-edge technologies such as artificial intelligence (AI) and the Internet of Things (IoT) to enhance people's quality of life.

Key Players Landscape and Outlook

The Japan medical imaging market is quite competitive with a major number of players at local levels as well. Regulatory approvals of company products, mergers and acquisitions, and collaborations are the most common market strategies that have been observed in recent times.

In July 2024, a group of researchers from RIKEN Center for Advanced Intelligence Project (AIP) has received regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for a novel AI-based ultrasound systems that supports in the fetal cardiac ultrasound screening.

In April 2023, EDAP TMS SA (EDAP), received Japan the Pharmaceutical and Medical Devices Agency (PDMA) approval for commercialization of the ExactVu micro-ultrasound biopsy platform. The company is aimed to tap growing opportunities in the country, as Japan is second-largest market for novel medical technology platforms and rising prostate cancer patient population.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Medical Imaging Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. X-ray Devices
      • 4.2.1.1.1. Radiography
      • 4.2.1.1.2. Fluoroscopy
      • 4.2.1.1.3. Mammography
    • 4.2.1.2. Ultrasound
      • 4.2.1.2.1. Handheld
      • 4.2.1.2.2. Compact
    • 4.2.1.3. Computed Tomography (CT)
      • 4.2.1.3.1. High-end Slice CT
      • 4.2.1.3.2. Mid-end Slice CT
      • 4.2.1.3.3. Low-end Slice CT
      • 4.2.1.3.4. Cone Beam CT
    • 4.2.1.4. Magnetic Resonance Imaging (MRI)
      • 4.2.1.4.1. Closed System
      • 4.2.1.4.2. Open System
    • 4.2.1.5. Nuclear Imaging
      • 4.2.1.5.1. SPECT
      • 4.2.1.5.2. PET
  • 4.2.2. By Application
    • 4.2.2.1. Cardiology
    • 4.2.2.2. Oncology
    • 4.2.2.3. Neurology
    • 4.2.2.4. Orthopedics
    • 4.2.2.5. Gastroenterology
    • 4.2.2.6. Gynecology
    • 4.2.2.7. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Diagnostic Imaging Centers
    • 4.2.3.3. Others
  • 4.2.4. By Region
    • 4.2.4.1. North [Hokkaido and Tohoku]
    • 4.2.4.2. Central [Kanto and Chubu]
    • 4.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players*
  • 16.3.1. Canon Medical Systems Corporation
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 16.3.2. Siemens Healthineers AG
  • 16.3.3. GE HealthCare Technologies Inc.
  • 16.3.4. Koninklijke Philips N.V.
  • 16.3.5. Esaote SpA
  • 16.3.6. Shimadzu Corporation
  • 16.3.7. FUJIFILM Holdings Corporation
  • 16.3.8. Samsung Electronics Co Ltd.
  • 16.3.9. United Imaging Healthcare Japan
  • 16.3.10. Carestream Health Japan Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Medical Imaging Market, By Value, In USD Billion, FY2018-FY2032F
• Figure 2. Japan Medical Imaging Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. Japan Medical Imaging Market Share (%), By Product, FY2018-FY2032F
• Figure 4. Japan Medical Imaging Market Share (%), By Application, FY2018-FY2032F
• Figure 5. Japan Medical Imaging Market Share (%), By End-user, FY2018-FY2032F
• Figure 6. Japan Medical Imaging Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Product Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 8. By Application Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 9. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 10. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2024